Reputable suppliers use insulated packaging and cold packs for warm-weather shipments
Similarly, in the group with obesity, 6.7% of those taking semaglutide developed NAION, compared with only 0.8% of those taking other medications
This is not a contraindication to treatmentit is a reason for more intentional oversight and potential dose adjustment
Cancelas J, Gottschall J, Rugg N, Graminske S, Schott M, North A, et al
Key Benefits of Semaglutide Treatment Patients receiving semaglutide under medical supervision commonly experience significant appetite suppression and reduced food cravings, meaningful reduction in visceral abdominal fat, improved cardiovascular markers including lower blood pressure and healthier cholesterol levels, better blood sugar control and increased insulin sensitivity, enhanced energy levels and improved psychological well-being, and sustained weight loss when combined with lifestyle modifications